Dr David Roblin, chief operating officer and director of scientific translation at the Francis Crick Institute in London, talks to EPM about the Institute’s recent partnership with GSK that will address a number of disease areas
As October is Breast Cancer Awareness month EPM has put together a list of medical developments and partnerships in the pharmaceutical sector that are helping to treat cancer
Scientists have identified that glucose fuels the growth of cancer. The particular protein that fuels this growth is PARP14. They hope to create a drug which inhibits PARP 14, starves the cancerous cells and, in the future, can be used to cure cancer
Angle’s Andrew Newland talks to EPM about the high level of interest from across the globe in the company’s cell separation technology, which captures cancer cells circulating in the blood and harvests those cells for analysis
Dr. Paul Clewlow, Sygnature Discovery, talks to EPM about the company’s successful track record in discovering medicines for the benefit of “patients with debilitating diseases such as cancer”
Discussing the potential “doomsday scenario” of a world without antibiotics, Professor Colin Garner, chief executive of Antibiotic Research UK (ANTRUK), says “not all is…bleak” as efforts are being made to remedy the situation
According to a study published in the Pertanika Journal of Tropical Agricultural Science, garlic extract could prove effective in combating animicrobial resistant strains of pathogenic bacteria associated with urinary tract infection.
The advances made in the pharma sector are well documented. Whether we are looking at drug development for stopping smoking or the latest cancer fighting formulations, the range of groundbreaking pharmaceutical products continues to increase.
